Couverture de The Business of Eye Innovation

The Business of Eye Innovation

The Business of Eye Innovation

De : Medevise Consulting
Écouter gratuitement

À propos de ce contenu audio

The podcast that explores insight, trends and opinion in the business of European ophthalmology.Copyright 2021 All rights reserved. Hygiène et vie saine Maladie et pathologies physiques
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Episode 21 - What is Happening with MDR?
      Jan 7 2025

      In this episode of the BOEI Podcast, we discuss what is happening with MDR in Europe .

      Learn more about our guests:

      • Kristine Morrill - https://www.linkedin.com/in/kamorrill/
      • Merlin Rietschel - https://www.linkedin.com/company/medtech-europe/
      • Eric Vollebregt - https://www.linkedin.com/in/erikvollebregt/?originalSubdomain=nl
      • Gert Boss - https://www.linkedin.com/in/gertbos/?originalSubdomain=nl

      Follow Medevise on LinkedIn.

      Afficher plus Afficher moins
      1 h et 7 min
    • Episode 20 -The Things We Do Not Talk About in Ophthalmology
      Jun 24 2024

      On this episode of the BOEI Podcast, Prof Burkhard Dick talks with Kris Morrill about the impact on eyecare from our living longer, as more patients present with neurological diseases including dementia, which is often not diagnosed.

      > Learn more + key takeaways

      Afficher plus Afficher moins
      32 min
    • Episode 19 - The IOL: Celebrating 75 Years
      Apr 16 2024

      On this episode of the BOEI Podcast, we’re reflecting on the significance of the IOL in modern eye care and the impact created by it’s invention 75 years ago. Together with Tim Clover (CEO fo Rayner), David Lockington (president-elect UKISCRS), and Paul Ursell (incumbent president UKISCRS), we discuss what the IOL has meant for the evolution of eye care, and how our field is celebrating this important innovation.

      > Learn more + key takeaways

      Afficher plus Afficher moins
      28 min
    Aucun commentaire pour le moment